This hypothesis is supported by the observation that inhibitors of glycolysis-related molecules, such as hypoxia-inducible factor 1α [34,35], glucose transporter 1 [36,37], carbonic anhydrase IX [38], and monocarboxylate transporter 4 [39], suppress tumor progression in several types of cancer, including breast cancer. Here, CA9 is linked to breast carcinoma.